U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07385131) titled 'Prophylactic Dexamethasone Before Infliximab in Moderate-to-Severe IBD' on Jan. 27.
Brief Summary: This comparative observational cohort clinical study aims to investigate the necessity of premedication for allergy prevention prior to infliximab injection, and is designed to evaluate whether non-routine administration of dexamethasone before intravenous infusion of infliximab yields greater benefits than routine prophylactic medication in patients with moderate-to-severe inflammatory bowel disease (IBD). This study is designed to optimize the prophylactic strategy prior to Infliximab treatment and advocate for risk stratification-bas...